JP2006517032A - ある種の癌治療の有効性を評価するための方法 - Google Patents

ある種の癌治療の有効性を評価するための方法 Download PDF

Info

Publication number
JP2006517032A
JP2006517032A JP2006503077A JP2006503077A JP2006517032A JP 2006517032 A JP2006517032 A JP 2006517032A JP 2006503077 A JP2006503077 A JP 2006503077A JP 2006503077 A JP2006503077 A JP 2006503077A JP 2006517032 A JP2006517032 A JP 2006517032A
Authority
JP
Japan
Prior art keywords
sample
kda
therapeutic agent
caspase
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006503077A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006517032A5 (https=
Inventor
エスター・エイチ・チャン
キャスリーン・エフ・ピロロ
アントニア・ライト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Publication of JP2006517032A publication Critical patent/JP2006517032A/ja
Publication of JP2006517032A5 publication Critical patent/JP2006517032A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2006503077A 2003-01-28 2004-01-28 ある種の癌治療の有効性を評価するための方法 Pending JP2006517032A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44290203P 2003-01-28 2003-01-28
PCT/US2004/002261 WO2004066946A2 (en) 2003-01-28 2004-01-28 Method for evaluating the efficacy of certain cancer treatments

Publications (2)

Publication Number Publication Date
JP2006517032A true JP2006517032A (ja) 2006-07-13
JP2006517032A5 JP2006517032A5 (https=) 2007-03-15

Family

ID=32825276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006503077A Pending JP2006517032A (ja) 2003-01-28 2004-01-28 ある種の癌治療の有効性を評価するための方法

Country Status (5)

Country Link
US (1) US20040241088A1 (https=)
EP (1) EP1595142A4 (https=)
JP (1) JP2006517032A (https=)
CA (1) CA2513769A1 (https=)
WO (1) WO2004066946A2 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022075439A1 (https=) * 2020-10-08 2022-04-14

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617514B2 (en) 1999-02-22 2013-12-31 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
AU2006304790B2 (en) * 2005-10-20 2013-06-27 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
CN102325719A (zh) 2008-12-30 2012-01-18 3M创新有限公司 纳米结构化制品和制备纳米结构化制品的方法
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
WO2020117715A1 (en) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Oligo-benzamide analogs and their use in cancer treatment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001522871A (ja) * 1997-11-19 2001-11-20 ジョージタウン・ユニバーシティ 標的化リポゾーム遺伝子送達
JP2002537318A (ja) * 1999-02-22 2002-11-05 ジョージタウン・ユニバーシティ 全身性遺伝子送達のための抗体標的化フラグメントイムノリポソーム
JP2002537818A (ja) * 1999-03-05 2002-11-12 アイドゥン ファーマシューティカルズ， インコーポレイテッド 膜由来カスパーゼ活性およびそのモジュレーターを検出する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462175B1 (en) * 1995-11-13 2002-10-08 Thomas Jefferson University Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001522871A (ja) * 1997-11-19 2001-11-20 ジョージタウン・ユニバーシティ 標的化リポゾーム遺伝子送達
JP2002537318A (ja) * 1999-02-22 2002-11-05 ジョージタウン・ユニバーシティ 全身性遺伝子送達のための抗体標的化フラグメントイムノリポソーム
JP2002537818A (ja) * 1999-03-05 2002-11-12 アイドゥン ファーマシューティカルズ， インコーポレイテッド 膜由来カスパーゼ活性およびそのモジュレーターを検出する方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022075439A1 (https=) * 2020-10-08 2022-04-14
WO2022075439A1 (ja) * 2020-10-08 2022-04-14 国立大学法人東海国立大学機構 抗トランスフェリンレセプター抗体の薬効又は感受性の判定方法

Also Published As

Publication number Publication date
WO2004066946A3 (en) 2005-08-18
CA2513769A1 (en) 2004-08-12
US20040241088A1 (en) 2004-12-02
WO2004066946A2 (en) 2004-08-12
EP1595142A4 (en) 2006-08-23
EP1595142A2 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
Pastorino et al. Targeting liposomal chemotherapy via both tumor cell–specific and tumor vasculature–specific ligands potentiates therapeutic efficacy
JP7386711B2 (ja) 腫瘍を治療するための方法
CN113164589A (zh) 用于调节单核细胞和巨噬细胞发炎表型的组合物和方法以及其免疫疗法用途
JP2014169293A (ja) Ｓｐａｒｃ及びその使用方法
JP2010046086A (ja) 悪性新生物の診断および処置
CN101932604A (zh) EphB4作为诊断标记和作为卵巢癌的治疗靶标的用途
US20070243548A1 (en) Calumenin-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
US20070122414A1 (en) Surface marker-directed cancer therapeutics
WO2004113497A2 (en) Gene delivery to tumors
US20070077583A1 (en) Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
JP2006517032A (ja) ある種の癌治療の有効性を評価するための方法
US20210069330A1 (en) Methods and compositions for tumor radiosensitization
US9078856B2 (en) Improving efficacy of cancer therapy
US20020156025A1 (en) Inhibition of vacuolar proton ATPase activity and/or the modulation of acidic organelle function sensitizes cells to radiation, chemotherapy and biological agents
US20130253039A1 (en) Colorectal cancer treatments and diagnostic improvements
US20110165173A1 (en) Therapeutic agent and detection reagent for arteriosclerotic disease which targets for salusin
KR20080003388A (ko) 진단 및 치료 방법, 및 이에 유용한 제제
Jones et al. Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury
US6235729B1 (en) Uses of phospholipase C inhibitors
US20030144236A1 (en) Novel specific inhibitor of the cyclin kinase inhibitor p21 (wafl/cip1)
JP2006517032A5 (https=)
CA3235029A1 (en) Method of cancer treatment
US9644019B2 (en) Compounds for treating cardiac damage after ischaemia/reperfusion
Guo et al. DCR2-targeted ultrasound nanobubbles loaded with verteporfin promote M2 macrophage polarization to overcome doxorubicin resistance in breast cancer
US8066971B2 (en) Targeting pulmonary epithelium using ADRP

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070123

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070123

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20091105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100406